Skip to main content
. 2022 Apr 7;13:1891. doi: 10.1038/s41467-022-29413-2

Fig. 1. Compound 4, GC376, MAC-5576, and ebselen inhibited SARS-CoV-2 3CL protease.

Fig. 1

a Structures of compound 4, GC376, MAC-5576, and ebselen. b The dose-dependent effects of compound 4, GC376, MAC-5576, and ebselen on the activity of 200 nM SARS-CoV-2 3CL protease were tested. The fluorogenic peptide MCA-AVLQSGFR-Lys(DNP)-Lys-NH2, corresponding to the nsp4/nsp5 cleavage site in the virus was applied as substrate. Data are plotted as the mean ± s.d., n = 3 biological replicates. Source data are provided as a Source Data file.